A carregar...
A Phase II Trial and Pharmacokinetic Study of Oxaliplatin in Children with Refractory Solid Tumors: A Children's Oncology Group Study
BACKGROUND: Platinating agents are used in the treatment of a spectrum of childhood cancers. Oxaliplatin, a third generation platinum compound, may provide less toxicity and be more effective. A phase 2 study was performed to estimate the response rate to single agent oxaliplatin in patients with re...
Na minha lista:
| Publicado no: | Pediatr Blood Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4665115/ https://ncbi.nlm.nih.gov/pubmed/20658614 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.22544 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|